(Q48512045)

12 February 2018

reason for preferred rank

title

Mechanisms of oligodendrocyte interaction with normal human serum - defining the role of complement (English)

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

17 October 2022

Mechanisms of oligodendrocyte interaction with normal human serum--defining the role of complement (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624954

17 October 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

17 October 2022

author name string

J. Zajicek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624954

17 October 2022

M. G. Wing

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624954

17 October 2022

P. J. Lachmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624954

17 October 2022

D. A. Compston

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624954

17 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1624954

17 October 2022

publication date

1 March 1992

1 reference

12 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0022510X9290189R?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

https://api.elsevier.com/content/article/PII:0022510X9290189R?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Journal of the Neurological Sciences

17 October 2022

published in

1 reference

12 February 2018

volume

108

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

65-72

1 reference

12 February 2018

Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

The pathogenesis of demyelinating disease: insights from cell biology

17 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway

17 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Antibody-independent complement activation by myelin via the classical complement pathway

17 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

17 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

The unactivated form of the first component of human complement, C1

17 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Multiple sclerosis: serum gamma globulin and demyelination in organ culture

17 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

The binding and activation of the C1r-C1s subunit of the first component of human complement

17 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Immunofluorescence demonstration of 2′:3′-cyclic-nucleotide 3′-phosphodiesterase in cultured oligodendrocytes of mouse, rat, calf and human

17 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

17 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

17 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

B cells and antibodies in MS.

17 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Lessons from magnetic resonance imaging in multiple sclerosis

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

17 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis

17 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

The neuropathology of multiple sclerosis

17 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium

17 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.

17 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies

17 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Functional properties of membrane cofactor protein of complement

17 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Tissue culture demyelination by normal human serum

17 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels

17 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies

17 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Activation of complement by myelin: identification of C1-binding proteins of human myelin from central nervous tissue

17 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody

17 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls

17 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0022-510X(92)90189-R

17 October 2022

Identifiers

1 reference

12 February 2018

1 reference

12 February 2018